跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
哈药六厂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Paracetamol and Amantadine Hydrochloride Capsules
Approved
化学药品
Compound Paracetamol and Amantadine Hydrochloride Capsules
哈药集团制药六厂
🇨🇳 National Medical Products Administration
Approval Date
Apr 23, 2020
Approval ID
7LeaeLF5ctr
Company
哈药集团制药六厂
Type
化学药品
Approval Details
Approval Id
7LeaeLF5ctr
Approval Number
国药准字H23023415
Generic Name
复方氨酚烷胺胶囊
Generic Name En
Compound Paracetamol and Amantadine Hydrochloride Capsules
Brand Name
哈药六厂
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
复方
Reg Date
2020-04-23
Company Name
哈药集团制药六厂
Production Company Name
哈药集团制药六厂
Production Company Address
哈尔滨市道外区南直路326号
Company Detail Path
/organization/ha-yao-ji-tuan-zhi-yao-liu-han
Production Company Detail Path
/organization/ha-yao-ji-tuan-zhi-yao-liu-han
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 23, 2020
Approval ID
7LeaeLF5ctr
Type
化学药品
Back to NMPA Approvals